The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time the combined respiratory viral vaccine will be approved. “EMA has recommended granting a marketing authorisation in the European Union (EU) for mCombriax, a messenger RNA vaccine…
